IL-6 has been previously implicated in the pathogenesis of hematological malignancies, like multiple myeloma39, Hodgkin’s lymphoma40, CML41,42, CMML43, and solid cancers, like breast44, prostate45, and pancreatic cancer46. This evidence concerns the gene IL6 and hematologic disorder.